20 LATEST RESOURCES (197 INDEXED)
Psychiatric Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Pharmacovigilance Analysis of Individual Case Safety Reports Submitted to the Eudravigilance Database · January 2024
Articles
International Journal of Clinical Pharmacy
Efficacy of Multidisciplinary Interventions in Preventing Metabolic Syndrome and Improving Body Composition in Prostate Cancer Patients Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis · September 2023
Articles
Clinical Nutrition ESPEN
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
Association between Antipsychotic Medication and Clinically Relevant Weight Change: Meta-Analysis · January 2023
Articles
BJPsych Open
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Schizophrenia Bulletin
Metformin in the Management of Antipsychotic-Induced Weight Gain in Adults with Psychosis: Development of the First Evidence-Based Guideline Using GRADE Methodology · September 2021
Articles
Evidence-Based Mental Health
The Association between BDNF Levels and Risperidone-Induced Weight Gain Is Dependent on the BDNF Val66Met Polymorphism in Antipsychotic-Naive First Episode Schizophrenia Patients: A 12-Week Prospective Study · September 2021
Articles
Translational Psychiatry
Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis · July 2021
Articles
Frontiers in Endocrinology
Effect of Bifidobacterium on Olanzapine-Induced Body Weight and Appetite Changes in Patients with Psychosis · May 2021
Abstracts
Psychopharmacology
Weight Gain in Veterans Taking Duloxetine, Pregabalin, or Both for the Treatment of Neuropathy · May 2021
Articles
NCBI>Federal Practitioner
Long-Term Psychoeducation in Limiting Body Mass Gain in Patients Treated with Atypical Antipsychotics · April 2021
Articles
Psychiatria Polska
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Metformin Reduces 12-Month Change in Body Weight among People Newly Commenced on Clozapine: A Retrospective Naturalistic Cohort Study · March 2021
Articles
Therapeutic Advances in Psychopharmacology
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children · March 2021
Articles
Frontiers in Psychiatry
Risperidone-Induced Obesity in Children and Adolescents with Autism Spectrum Disorder: Genetic and Clinical Risk Factors · November 2020
Articles
Frontiers in Pharmacology